Characteristics of Patients With Type 2 Diabetes Mellitus Receiving Treatment With Dapagliflozin Versus Sitagliptin: An Analysis of Commercial Claims and Linked Laboratory Data
Clinical trial NCT03078049 · COMPLETED
Trial details
- NCT number
- NCT03078049
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2017-03-31
- Primary completion
- 2017-04-30
- Enrollment
- 11971
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.